本周街头分析师评级与个股反应

Investing.com -- Takeovers, a failed pipeline and a Medicare scorecard drove this week’s biggest reactions, more than any change in analyst views. I picked one upgrade or downgrade per day, choosing the stock with the largest reported percentage move. Maintains and price-target-only changes were excluded. Several moves are intraday or premarket snapshots, so closing figures may differ.

Monday, Oct 5: Deal caps PTC’s upside

Stifel downgraded PTC (PTC) to Hold from Buy and raised its target to $205 from $165. Schneider Electric agreed to buy the company for $205 per share in cash, a 42% premium to Friday’s close. Shares traded near $192.99, which implies a gain of roughly 34% (my calculation from the stated premium). Rosenblatt made the same Buy-to-Neutral move.

The downgrade reflects a stock that now trades to a deal price, not a thesis gone sour. With the target pinned to the offer, little upside remains. Read more (Oct 5, 2026)

Tuesday, Oct 6: Blaize unravels

Rosenblatt cut Blaize Holdings (BZAI) to Neutral from Buy with a $0.40 target. Craig-Hallum moved it to Hold from Buy. Shares fell more than 30% in morning trading. The company reported third-quarter revenue of just $0.5 million and cut its 2026 guidance to $32M to $36M from $40M to $43M. It also disclosed Department of Justice subpoenas.

Rosenblatt questioned whether Blaize can fulfill a $50 million contract, noting a buyer had paid only $0.2 million of a $13.3 million receivable. The downgrades followed the company’s own disclosures. Read more (Oct 6, 2026)

Barclays upgraded Fortrea, whose shares rose about 8.7%. That was a smaller move than Blaize’s drop.

Wednesday, Oct 7: Caribou abandons its pipeline

Caribou Biosciences (CRBU) fell 35.7% in pre-open trading to $0.73. The company is dropping both allogeneic CAR-T programs and exploring strategic alternatives. RBC cut it to Sector Perform from Outperform and slashed its target to $1 from $10. Leerink moved to Market Perform, with a $1 target against $4 before.

Leerink said investors would not fund the Phase 3 trial on dilutive terms. The stock had a market cap near $122 million before the news. Read more (Oct 7, 2026)

Thursday, Oct 8: First Sell on Universal Display

Citi downgraded Universal Display (OLED) to Sell from Neutral and cut its target to $71 from $85. Shares slid 4.0% pre-open to $74.14. Reported as the first Sell rating ever assigned to the stock, the call came with the new target below the 52-week low of $73.23.

Second-quarter sales fell roughly 11% year over year to about $152M, and management guided to the low end of its $630M to $670M range. Citi cited smartphone weakness next year. Citi’s cuts of NXP (down 2.6% premarket) and Nova (down 2.9%) were smaller moves. Read more (Oct 8, 2026)

Friday, Oct 9: Humana gets its stars back

Baird upgraded Humana (HUM) to Outperform from Neutral and raised its target to $596 from $390. Shares closed at $431.87, up 11.56% (as of Oct 9, 3:59 PM EDT), after a session high of $456.50. CMS lifted Humana’s flagship H5216 contract back to 4 stars. About 95% of members will sit in 4-star-or-higher plans in 2027, against 20% in 2026. Evercore estimates about $4.8B in bonus payments in 2028.

Two bigger movers had no rating change behind them. Crown Castle (CCI) closed up 15.60% and Moderna (MRNA) up 14.21%. Those moves followed SpaceX’s spectrum deal and Nasdaq-100 inclusion, so they do not qualify. Baird warns the profit boost depends on reinvestment in member benefits. With shares roughly doubled in six months, much of the news may be priced in. Read more (Oct 9, 2026)

What tied the week together

Four of the five picks involved downgrades. Three came after the news (the takeover, the guidance cut and the pipeline shutdown), so those calls trailed the price. Citi’s Universal Display call was one of the few that ran ahead of events. Humana was the only upgrade among the winners. Rate worries kept a lid on sentiment by Friday. Read more (Oct 9, 2026)

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Street Calls of the Week

View all comments (0)0

Latest comments

Post

Comment Guidelines

Trade With A Regulated Broker

Indices Commodities Bonds Stocks

US 30

51,703.90

+472.2

+0.92%

US 500

7,816.30

+50.8

+0.65%

Dow Jones

51,654.95

+423.31

+0.83%

S&P 500

7,811.54

+46.18

+0.59%

Nasdaq

27,366.17

+172.83

+0.64%

S&P 500 VIX

14.84

-0.57

-3.70%

Dollar Index

102.03

+0.010

+0.01%

Crude Oil WTI Futures

91.66

+0.17

+0.19%

Brent Oil Futures

104.42

-0.30

-0.29%

Natural Gas Futures

3.20

+0.040

+1.14%

Gold Futures

4,220.30

+63.30

+1.52%

Silver Futures

61.11

+1.690

+2.84%

Copper Futures

6.71

+0.1400

+2.17%

US Soybeans Futures

1,292.25

+4.75

+0.37%

U.S. 10Y

5.244

+0.011

+0.21%

U.S. 30Y

5.599

-0.008

-0.14%

U.S. 5Y

5.021

+0.030

+0.60%

U.S. 3M

4.159

+0.008

+0.19%

US 10Y T-Note Futures

104.59

-0.13

-0.12%

Euro Bund Futures

121.08

+0.41

+0.34%

10-2 Yield Spread

31.32

+4.15

+15.27%

AAPL

336.64

-3.78

-1.11%

NVDA

229.28

-1.20

-0.52%

GOOGL

351.66

+3.37

+0.97%

TSLA

382.70

+7.70

+2.05%

AMZN

262.43

+8.37

+3.29%

NFLX

70.30

-1.27

-1.77%

Name	Last	Chg. %	Vol.
MU	1,029.00	-0.66%	19.92M
NVDA	229.28	-0.52%	84.65M
SPCX	162.57	+1.25%	93.04M
TSLA	382.70	+2.05%	38.95M
AAPL	336.64	-1.11%	37.88M
MSFT	535.07	+2.38%	18.50M
AMZN	262.43	+3.29%	34.77M

Name	Last	Chg. %	Vol.
CCI	79.64	+15.60%	14.39M
MRNA	225.00	+14.21%	28.95M
HUM	431.87	+11.56%	4.99M
AMT	182.24	+9.30%	8.51M
SBAC	182.49	+7.34%	2.36M
DDOG	293.26	+7.11%	3.71M
AKAM	106.95	+6.00%	5.80M

Name	Last	Chg. %	Vol.
TMUS	148.58	-13.27%	19.03M
T	22.18	-10.82%	150.53M
VZ	41.65	-10.14%	95.17M
HPQ	30.20	-6.91%	16.70M
FMC	8.35	-6.39%	5.19M
CHTR	103.38	-5.74%	5.11M
FICO	667.58	-5.63%	1.09M

Trending Stocks

Name	Last	Chg. %	Vol.
PLTR	209.05	+5.17%	37.62M
MRNA	225.00	+14.21%	28.95M
SPCX	162.57	+1.25%	93.04M
NVDA	229.28	-0.52%	84.65M
MU	1,029.00	-0.66%	19.92M

ProPicks AI

AI-powered stock picks with a proven track record to beat the S&P 500.

Tech Titans

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Top Value Stocks

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Best of Buffett

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Energy Elite

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Financial Fortresses

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Quality Compounders

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Small-Cap Sprinters

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Healthcare Heroes

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Beat the S&P 500

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Dominate the Dow

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Mid-Cap Movers

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Mexican Stock Exchange Leaders

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Best Brazilian Stocks

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Italian Market Elite

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Alpha Germany Select

Stocks in this Strategy

aaaa aaaaa aaaa a

Unlock Strategy

Comments

Post

Comment Guidelines

Tools

Calendars

Economic Calendar Earnings Calendar Holiday Calendar

US Economy

Fed Rate Monitor Tool US Treasury Yield Curve

More Tools

Stock Screener Currency Converter

Markets Ask WarrenAI Stocks Picked by AI Watchlist Alerts Top Brokers Breaking News Tools

Install Our App Scan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Mediawould like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.Fusion Mediaand any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.